Stephens Inc. AR Sells 17,168 Shares of Kenvue Inc. $KVUE

Key Points

• Stephens Inc. AR reduced its holdings in Kenvue Inc. by 9.8%, selling 17,168 shares, and now owns 158,519 shares valued at $3.32 million.
• Several institutional investors have increased their positions in Kenvue during the second quarter, with institutional ownership now at 97.64%.
• Recent analyst reports reflect a downward revision of Kenvue's price targets, with the average target now at $21.18 and multiple analysts recommending a "Hold" rating.

Stephens Inc. AR decreased its position in shares of Kenvue Inc. (NYSE:KVUE - Free Report) by 9.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 158,519 shares of the company's stock after selling 17,168 shares during the quarter. Stephens Inc. AR's holdings in Kenvue were worth $3,318,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Evergreen Wealth Solutions LLC lifted its holdings in shares of Kenvue by 2.6% in the first quarter. Evergreen Wealth Solutions LLC now owns 16,769 shares of the company's stock worth $402,000 after acquiring an additional 432 shares during the last quarter. Scott & Selber Inc. grew its position in shares of Kenvue by 0.4% during the 1st quarter. Scott & Selber Inc. now owns 106,621 shares of the company's stock worth $2,557,000 after buying an additional 475 shares during the period. Wealth Alliance LLC grew its position in shares of Kenvue by 1.6% during the 1st quarter. Wealth Alliance LLC now owns 31,778 shares of the company's stock worth $762,000 after buying an additional 486 shares during the period. Everett Harris & Co. CA grew its position in shares of Kenvue by 1.4% during the 1st quarter. Everett Harris & Co. CA now owns 36,971 shares of the company's stock worth $887,000 after buying an additional 500 shares during the period. Finally, Proffitt & Goodson Inc. grew its position in Kenvue by 8.2% in the 2nd quarter. Proffitt & Goodson Inc. now owns 6,831 shares of the company's stock valued at $143,000 after purchasing an additional 517 shares during the period. Institutional investors own 97.64% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have issued reports on KVUE shares. Citigroup cut their price objective on shares of Kenvue from $20.00 to $17.00 and set a "neutral" rating on the stock in a report on Thursday, October 9th. Evercore ISI lowered their price objective on Kenvue from $23.00 to $18.00 and set an "in-line" rating on the stock in a research note on Tuesday, September 23rd. UBS Group lowered their price objective on Kenvue from $23.00 to $17.00 and set a "neutral" rating on the stock in a research note on Wednesday, October 8th. Canaccord Genuity Group cut their price objective on Kenvue from $29.00 to $26.00 and set a "buy" rating for the company in a report on Friday, August 8th. Finally, The Goldman Sachs Group cut their price objective on Kenvue from $22.00 to $19.00 and set a "neutral" rating for the company in a report on Thursday, October 2nd. One investment analyst has rated the stock with a Strong Buy rating, five have given a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, Kenvue has an average rating of "Hold" and an average price target of $21.18.

Kenvue Stock Up 1.8%

Shares of KVUE opened at $15.20 on Thursday. The firm has a market cap of $29.16 billion, a P/E ratio of 20.53, a P/E/G ratio of 2.15 and a beta of 0.72. The stock has a 50 day simple moving average of $18.15 and a two-hundred day simple moving average of $20.89. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.98 and a quick ratio of 0.68. Kenvue Inc. has a 1 year low of $14.05 and a 1 year high of $25.17.

Kenvue (NYSE:KVUE - Get Free Report) last issued its earnings results on Thursday, August 7th. The company reported $0.29 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.01. The business had revenue of $3.84 billion during the quarter, compared to analyst estimates of $3.94 billion. Kenvue had a return on equity of 20.06% and a net margin of 9.37%.Kenvue's revenue for the quarter was down 4.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.32 earnings per share. Kenvue has set its FY 2025 guidance at 1.000-1.050 EPS. On average, analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, August 27th. Shareholders of record on Wednesday, August 13th were paid a $0.2075 dividend. This is an increase from Kenvue's previous quarterly dividend of $0.21. This represents a $0.83 annualized dividend and a yield of 5.5%. The ex-dividend date of this dividend was Wednesday, August 13th. Kenvue's payout ratio is currently 112.16%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.